老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ABVC BioPharma, Inc.

3.35
-0.2300-6.42%
盘后：3.370.0200+0.60%18:25 EDT
成交量：15.06万
成交额：51.79万
市值：5,444.07万
市盈率：-14.94
高：3.60
开：3.59
低：3.35
收：3.58
数据加载中...
总览公司新闻公告
2021/11/15

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/11/15

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/11/15

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/11/15

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/11/15

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/10/08

重要事件披露

8-K - Current report
2021/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/05

重要事件披露

8-K - Current report
2021/07/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/29

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/21

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/21

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/08

重要事件披露

8-K/A [Amend] - Current report
2021/05/14

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03

重要事件披露

8-K/A [Amend] - Current report
2021/04/08

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
更多